Express News | Esperion Strengthens Balance Sheet With Closing of Significant Refinancing Transactions

BreakingsDec 18 20:00

Goldman Sachs Upgrades Esperion Therapeutics(ESPR.US) to Hold Rating, Raises Target Price to $4

Futu NewsDec 18 14:31 · Ratings

Cantor Fitzgerald Initiates Esperion Therapeutics(ESPR.US) With Buy Rating, Announces Target Price $8

Futu NewsDec 18 06:31 · Ratings

Cantor Fitzgerald Initiates Esperion Therapeutics at Overweight With $8 Price Target

MT NewswiresDec 17 20:36 · Ratings

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 14 05:06

Needham Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $6

Futu NewsDec 14 02:31 · Ratings